MWP
ABBV icon

Meridian Wealth Partners’s AbbVie ABBV Stock Holding History

Meridian Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$706K Buy
2,807
+13
+0.5% +$2.8K 0.09% 56
2026
Q1 		$608K Buy
2,794
+217
+8% +$48.1K 0.08% 55
2025
Q4 		$589K Sell
2,577
-73
-3% -$16.6K 0.08% 54
2025
Q3 		$614K Sell
2,650
-2,356
-47% -$480K 0.08% 53
2025
Q2 		$929K Buy
5,006
+69
+1% +$12.8K 0.13% 45
2025
Q1 		$1.03M Sell
4,937
-282
-5% -$54.8K 0.17% 42
2024
Q4 		$927K Buy
5,219
+192
+4% +$35.3K 0.14% 42
2024
Q3 		$993K Buy
5,027
+14
+0.3% +$2.61K 0.15% 42
2024
Q2 		$860K Buy
5,013
+157
+3% +$26K 0.15% 41
2024
Q1 		$884K Buy
4,856
+141
+3% +$24.3K 0.16% 40
2023
Q4 		$731K Buy
4,715
+82
+2% +$12K 0.14% 42
2023
Q3 		$691K Buy
4,633
+150
+3% +$22K 0.14% 41
2023
Q2 		$604K Sell
4,483
-43
-1% -$6.31K 0.12% 43
2023
Q1 		$721K Buy
4,526
+71
+2% +$10.9K 0.16% 36
2022
Q4 		$720K Buy
4,455
+185
+4% +$28.4K 0.17% 35
2022
Q3 		$573K Buy
4,270
+19
+0.4% +$2.73K 0.14% 40
2022
Q2 		$652K Buy
4,251
+688
+19% +$105K 0.15% 38
2022
Q1 		$578K Buy
3,563
+1,653
+87% +$240K 0.12% 46
2021
Q4 		$258K Buy
+1,910
New +$226K 0.05% 71
2021
Q2 		– Sell
-652
Closed -$70K – 84
2021
Q1 		$70K Buy
652
+50
+8% +$5.35K 0.02% 133
2020
Q4 		$65K Buy
602
+269
+81% +$25.9K 0.03% 122
2020
Q3 		$29K Sell
333
-134
-29% -$12.6K 0.01% 169
2020
Q2 		$46K Buy
+467
New +$41.1K 0.02% 134

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Meridian Wealth Partners's ABBV Position: Q2 2026 in Review

Meridian Wealth Partners increased its AbbVie (ABBV) stake by 0.47% in Q2 2026, buying an estimated $2.8K and bringing the position to 2,807 shares worth $706K. The position accounts for 0.09% of the portfolio, ranked #56.

Meridian Wealth Partners first reported a position in ABBV in Q2 2020 and has held it in 23 quarters since. The position peaked at $1.03M in Q1 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Meridian Wealth Partners held 2,807 shares of AbbVie worth $706K as of Q2 2026.
  • Meridian Wealth Partners bought 13 AbbVie shares in Q2 2026, an estimated $2.8K.
  • AbbVie made up 0.09% of Meridian Wealth Partners's portfolio in Q2 2026, its #56 holding.
  • Meridian Wealth Partners first reported a position in AbbVie in Q2 2020 and has held it in 23 quarters since.
  • Meridian Wealth Partners's AbbVie position peaked at $1.03M in Q1 2025.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Meridian Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.